Features of diet therapy for Clostridium difficile- associated disease
https://doi.org/10.31146/1682-8658-ecg-205-9-229-239
Abstract
This review presents literature data on the prevalence, clinical picture, risk factors of development and modern approaches to diet therapy of the disease caused by Clostridium difficile (С. difficile). Particular attention is paid to modern methods of medical nutrition, taking into account the symptoms and factors of intoxication of the organism. Data on the possibility of using domestic products of dietary nutrition treatment for the restoration of the functions of the organism, the state of the microbiome, the detoxification of the organism and its rehydration have been analyzed.
About the Authors
T. L. Pilat
Izmerov Research Institute of Occupational Health
Russian Federation
Russian Federation
L. B. Lazebnik
Moscow State University of Medicine and Dentistry named after A. I. Evdakimov
Russian Federation
Russian Federation
Y. G. Kuznetzova
Peoples’ Friendship University of Russia (RUDN University)
Russian Federation
Russian Federation
R. A. Khanferyan
Peoples’ Friendship University of Russia (RUDN University)
Russian Federation
Russian Federation
References
1. Ivashkin V.T., Yushchuk N. D., Maev I. V. Rekomendatsii Rossiiskoi gastroenterologicheskoi assotsiatsii po diagnostike i lecheniyu Clostridiumdifficile-assotsiirovannoi bolezni. Ros.zhurn. gastroenterol. gepatol. koloproktol., 2016; 26(5), str. 56-65.
2. Zhdanov K.V. s soavt. Metodicheskie rekomendatsii po profilaktike, diagnostike i lecheniyu dizenterii i drugikh ostrykh kishechnykh diareinykh infektsii v Vooruzhennykh silakh Rossiiskoi Federatsii. Ostrye kishechnye diareinye infektsii. Ukazaniya po diagnostike, lecheniyu i profilaktike v Vooruzhennykh silakh Rossiiskoi Federatsii, M. 2019, 136 s.
3. Osadchuk M.A., Svistunov A. A. Antibiotikoassotsiirovannaya diareya v klinicheskoi praktike// Voprosysovremennoipediatrii /2014/ Tom 13/ № 1
4. Cohen S. H. et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect. Control Hosp. Epidemiol. 2010; 31 (5): 431-455.
5. IvashkinV.T., Shifrin O. S., Tertychnyi A. S., Poluektova E. A., Lapina T. L., Lyashenko O. S., Ivashkin K. V. Clostridium difficile-assotsiirovannaya bolezn'// Ros.zhurn.gastroenterol. gepatol. koloprok., 2015. - № 25(6). - S5-17.
6. Bauer M et al. Clinical and microbiological characteristics of community-onset Clostridium difficile infection in the Netherlands.Clin.Microbiol. Infect. 2009; 15: 1087-1092.
7. Bauer T. M., Lalvani A., Fehrenbach J. et al. Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA.2001; 285: 313-319.
8. Clifford L., McDonald et al. An epidemic, toxin gene-variant strain of Clostridium difficile.N.Engl. J. Med. 2005; 353: 2442-2249.
9. Korneeva O.N., Ivashkin V. T. Antibiotikoassotsiirovannyi kolit: patomorfologiya, klinika, lechenie. RZhGGK, № 3, 2007, str. 65-70.
10. Shifrin O. S. Antibiotikoassotsiirovannye porazheniya kishechnika: Spravochnik poliklinicheskogo vracha. - 2005. - T. 4, № 4. - S. 38-41.
11. Thibault R., Graf S., Clerc A., Delieuvin N., Heidegger C. P., Pichard C. Diarrhoea in the ICU: respective contribution of feeding and antibiotics. CritCare 2013; 17(4):153.
12. Shelygin Yu.A., Aleshkin V. A., Sukhina M. A. Klinicheskie rekomendatsii po diagnostike, lecheniyu i profilaktike Clostridium difficile-assotsiirovannoi diarei. Klinicheskie rekomendatsii. - M., 2017. - 24 s.
13. Sheptulin A. A. Refrakternye i retsidiviruyushchie formy kolita, assotsiirovannogo s Clostridium difficile //Rossiiskii zhurnal gastroenterologii, gepatologii i koloproktologii. - 2011. - T. 2. - S. 50-53.
14. Safin A. L., Achkasov S. I., Sukhina M. A. Sushkov O. I. Faktory riska razvitiya diarei, assotsiirovannoi s Slostridium difficile, u koloproktologicheskikh bol'nykh (obzor literatury). Koloproktologiya. - 2017. - № 1(59). - C. 59-67.
15. Surawicz S.M., Brandt L. J., Binion D. G., Ananthakrishnan A. N., Curry S. R., Gilligan P. H., McFarland L.V., Mellow M., Zuckerbraun B. S. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections Am J Gastroenterol 2013; 108(4):478-98.
16. Nikolaeva I. V., Shestakova I. V., Murtazina G. Kh. Sovremennye strategii diagnostiki i lecheniya Clostridiumdifficile-infektsii(obzor literatury). ActaBiomedica Scientifica.-2018. - № 3.-s.34-42.
17. Debast S.B., Bauer M. P. European society of clinical microbiology and infectious diseases: Update of the treatment guidance document for Clostridium difficile infection. ClinMicrobiolInfect 2014; 20 (2):45-48.
18. Zakharova N. V., Fil' T. S. Mikrobiologicheskie i klinicheskie osobennosti infektsii Clostridium difficile. Klinicheskaya mikrobiologiya i antimikrobnaya terapiya.-2002.-T.4, № 3. - s. 200-232.
19. Sun X., Savidge T., Feng H. Theenterotoxicity of Clostridium difficile toxins. Toxins (Basel) 2010; 2(7):1848-80.
20. Warny M., Pepin J., Fang A., Killgore G., Thompson A., Brazier J., Frost E., McDonald L. C. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366(9491):1079-84.
21. McDonald L.C., Killgore G. E., Thompson A., Owens R. C. Jr., Kazakova S. V., Sambol S. P., Johnson S., Gerding D. N. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353(23):2433-41.
22. Geric B., Rupnik M., Gerding D. N., Grabnar M., Johnson S. Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital. J Med Microbiol 2004; 53(Pt 9):887-94.
23. Lobzin Yu. V., Zakharenko S. M., Ivanov G. A. Sovremennye predstavleniya ob infektsii Clostridium difficile //Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya. - 2002. - T. 4. - №. 3. - S. 200-232.
24. Surawicz S.M., Brandt L. J., Binion D. G., Ananthakrishnan A. N., Curry S. R., Gilligan P. H., McFarland L.V., Mellow M., Zuckerbraun B. S.Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections Am J Gastroenterol 2013; https://doi.org/4):478-498.doi:10.1038.ajg.2013.4
25. Nelson R. L., Suda K. J., Evans C. T. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrana database Syst Rev.-2017.Mar 3.-vol.3. - P. https://doi.org/04610.DOI:10.1002.14651858.CD 004610.pub.5
26. Tkachenko E. I., Ivanov S. V., Sitkin S. I., Mesto nutritsionnoi podderzhki v terapii vospalitel'nykh zabolevanii kishechnika. Gastroenterologiya Sankt-Peterburga № 4, 2008. - str. 11-13.
27. Kozlov R. S., Shelygin Yu. A., Veselov A. V. i dr. Obzor obnovlennykh prakticheskikh rekomendatsii Amerikanskogo obshchestva po infektsionnym boleznyam(IDSA) i amerikanskogo obshchestva epidemiologii zdravookhraneniya(SHEA) po infektsiyam, vyzvannym Clostridium difficile, u detei i vzroslykh. KMAKh.-2018.-№ 20(2). - S. 46-124.
28. Skazyvaeva E.V., Skalinskaya M. I., Bakulin I. G. Obnovlennye klinicheskie rekomendatsii po infektsii Clostridium difficile Amerikanskogo obshchestva spetsialistov po infektsionnym boleznyam(IDSA) i Amerikanskogo obshchestva spetsialistov v oblasti epidemiologii zdravookhraneniya (SHEA): kratkii obzor osnovnykh polozhenii, kriticheskie zamechaniya i vozmozhnye perspektivy. Eksperimental'naya i klinicheskaya gastroenterologiya. - 2019.-№ 5(165).-s.3-14.
29. Prikaz Minzdrava RF ot 5 avgusta 2003 g. N 330 «O merakh po sovershenstvovaniyu lechebnogo pitaniya v lechebno-profilakticheskikh uchrezhdeniyakh Rossiiskoi Federatsii» (s izmeneniyami i dopolneniyami).
30. Baranovskii A. Yu. Dietologiya. 5-e izd.-SPb.: Piter, 2017. -1104s.
31. Rukovodstvo po gastroenterologii / Pod red. F. I. Komarova, S. I. Rapoporta. - M.: Meditsinskoe informatsionnoe agentstvo, 2010. - 864 s.
32. Spravochnik po dietologii /V. A. Tutel'yan, M. A. Samsonov. - M.: Meditsina, 2002.; Izdatel'stvo: Meditsina; 2002 g.; S. 544.
33. Pilat T.L., Kuz'mina L. P., Izmerova I. I. Detoksikatsionnoe pitanie / pod red. T. L. Pilat. - M.: GEOTAR-Media, 2012.-688 s.
34. Shul'pekova Yu. O. Antibiotikoassotsiirovannaya diareya//RMZh. - № 6. - S. 467.
35. Loshua R., Fletcher, et al. Clostridioidesdifficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude completitors from the gut microbiota.// Nature Communications.-№ 462, Published: 19 January 2021; https://doi.org/10.1038/s41467-020-20746-4
36. Mikrobiomvmeditsine: rukovodstvodlyavrachei / I. O. Stoma. - Moskva: GEOTAR-Media, 2020. - 320 s.
37. Prakticheskie rekomendatsii Nauchnogo soobshchestva po sodeistviyu klinicheskomu izucheniyu mikrobioma cheloveka (NSOIM) i Rossiiskoi gastroenterologicheskoi assotsiatsii (RGA) po primeneniyu probiotikovdlya lecheniya i profilaktiki zabolevanii gastroenterologicheskogoprofilya u vzroslykh / V. T. Ivashkin, I. V. Maev, D. I. Abdulganieva, S. A. Alekseenko, N. Yu. Ivashkina, N. V. Korochanskaya, S. N. Mammaev, E. A. Poluektova, A. S. Trukhmanov, Yu.P. - M., 2020.
38. MsFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the theatment of in Clostridium difficile disease.// Am J Gastroenterol, 2006. - 101, P. 812-822.
39. Paredes-Sabja D., Shen A., Sorg J. A. Clostridium difficile spore biology: spotulation, germination, and spore structural proteins. Trends Vicrobiol, 2014. - № 22. - P. 406-416.
40. McFarland L. V. Diarrhea acquired in the hospital // Gastroenterol. Clin.NorthAm. 1993.-№ 22. - P. 563-577.
41. Gilca R, Hubert B, Fortin E, Gaulin C, Dionne M. Epidemiological patterns and hospital characteristics associated with increased incidence of Clostridium difficile infection in Quebec, Canada, 1998-2006. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America. 2010;31(9):939-47. 10.1086/655463
42. Lechebnoe pitanie pri khronicheskikh zabolevaniyakh / B. S. Kaganov, Kh. Kh. Sharafetdinov - M.: Eksmo, 2016. - 272 s.
43. Hurley BW, Nguyen CC. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Archives of internal medicine.2002;162(19):2177-84.
44. Vollaard EJ, Clasener HA. Colonization resistance. Antimicrobial agents and chemotherapy. 1994;38(3):409-14.,
45. Wilson KH. The microecology of Clostridium difficile. Clinical infectious diseases: an official publication of the infectious Diseases Society of America. 1993;16 Suppl 4: S214-8.
46. Tutel'yan V. A., Gapparov M. M.G., Baturin A. K. idr. Semidnevnye menyu dlya osnovnykh variantov standartnykh diet s ispol'zovaniem blyud optimizirovannogo sostava, primenyaemykh v lechebnom pitanii v meditsinskikh organizatsiyakh Rossiiskoi Federatsii. /Prakticheskoe rukovodstvo dlya vrachei-dietologov, meditsinskikh sester dieticheskikh, spetsialistov po organizatsii pitaniya v statsionarnykh uchrezhdeniyakh spetsial'nogo obsluzhivaniya grazhdan pozhilogo vozrasta i invalidov, spetsialistov obshchestvennogo pitaniya. / Moskva, 2014. - 460 s.
47. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. The New England journal of medicine. 1994;330(4):257-62. 10.1056/NEJM199401273300406.
48. Karlstrom O, Fryklund B, Tullus K, Burman LG. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden.The Swedish C. difficile Study Group. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 1998;26(1):141-5.
49. Pepin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2005;41(9):1254-60. 10.1086/496986
50. Guerrant RL, Oria RB, Moore SR, Oria MO, Lima AA. Malnutrition as an enteric infectious disease with long-term effects on child development. Nutrition reviews. 2008;66(9):487-505. 10.1111/j.1753-4887.2008.00082.x
51. Bolick DT, Roche JK, Hontecillas R, Bassaganya-Riera J, Nataro JP, Guerrant RL. Enteroaggregative Escherichia coli strain in a novel weaned mouse model: exacerbation by malnutrition, biofilm as a virulence factor and treatment by nitazoxanide. Journal of medical microbiology. 2013;62(Pt 6):896-905. 10.1099/jmm.0.046300-0
52. Costa LB, JohnBull EA, Reeves JT, Sevilleja JE, Freire RS, Hoffman PS, et al. Cryptosporidium-malnutrition interactions: mucosal disruption, cytokines, and TLR signaling in a weaned murine model. The Journal of parasitology. 2011;97(6):1113-20. 10.1645/GE-2848.1
53. Bartelt LA, Roche J, Kolling G, Bolick D, Noronha F, Naylor C, et al. Persistent G. lamblia impairs growth in a murine malnutrition model. The Journal of clinical investigation. 2013;123(6):2672-84. 10.1172/JCI67294
54. Moore JH, Pinheiro CC, Zaenker EI, Bolick DT, Kolling GL, van Opstal E, Noronha FJ, De Medeiros PH, Rodriguez RS, Lima AA, Guerrant RL, Warren CA. Defined Nutrient Diets Alter Susceptibility to Clostridium difficile Associated Disease in a Murine Model. PLoSOne. 2015 Jul 16;10(7): e0131829. https://doi.org/10.1371/journal.pone.0131829.
55. Lamouse-Smith ES, Tzeng A, Starnbach MN. The intestinal flora is required to support antibody responses to systemic immunization in infant and germ free mice. PloSone. 2011;6(11): e27662 10.1371/journal.pone.0027662).
56. Ling Z, Liu X, Jia X, Cheng Y, Luo Y, Yuan L, et al. Impacts of infection with different toxigenic Clostridium difficile strains on faecalmicrobiota in children. Scientificreports. 2014;4:7485 10.1038/srep07485).
57. Hussein HS, Campbell JM, Bauer LL, Fahey GC, Hogarth AJ, Wolf BW, et al. Selected fructooligosaccharide composition of pet-food ingredients. The Journal of nutrition.1998;128(12 Suppl):2803S-5S.
58. Bosscher D, Breynaert A, Pieters L, Hermans N. Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects. Journal of physiology and pharmacology: an official journal of the Polish Physiological Society. 2009;60 Suppl 6:5-11.
59. Ikeda D, Karasawa T, Yamakawa K, Tanaka R, Namiki M, Nakamura S. Effect of isoleucine on toxin production by Clostridium difficile in a defined medium. Zentralblatt fur Bakteriologie: international journal of medical microbiology. 1998;287(4):375-86.
60. Metodicheskie rekomendatsii «Nutritsiologicheskaya profilaktika i reabilitatsiya pri zabolevaniyakh zheludochno-kishechnogo trakta / Pilat T. L., Kuz'mina L. P., Gurevich K. G. idr. - M. - 2019. - 36 s.
61. Pilat T. L., Kuz'mina L. P., Lashina E. L., Kolyaskina M. M., Bezrukavnikova L. M., Bessonov V. V., Korosteleva M. M., Gurevich K. G., Lagutina N. P., Khanfer'yan R. A. Ovsyanaya kasha s travami i semenami l'na sposobstvuet umen'sheniyu abdominal'nogo bolevogo sindroma pri zabolevaniyakh zheludochno-kishechnogo trakta//Dokazatel'naya gastroenterologiya. - T. № 9, № 1 (2). - 2020. - S. 26-35.
62. Pilat T.L., Khanfer'yan R. A. Spetsializirovannye dieticheskie produkty kak faktory povysheniya effektivnosti farmakoterapii zheludochno-kishechnykh zabolevanii//Terapiya. - № 6. - 2020. - S. 212-218.
63. Pilat T.L., Kuz'mina L. P., Lashina E. L., Kolyaskina M. M., Bezrukavnikova L. M., Bessonov V. V., Korosteleva M. M., Gurevich K. G., Lagutina N. P., Khanfer'yan R. A. Opyt primeneniya spetsializirovannogo pishchevogo produkta dieticheskogo lechebnogo i dieticheskogo profilakticheskogo pitaniya pri vospalitel'nykh zabolevaniyakh zheludochno-kishechnogo trakta. Meditsinskii sovet. 2020;(4):107-113.
64. Pilat T.L., Lashina E. L., Kolyaskina M. M., Bezrukavnikova L. M., Bessonov V. V., Korosteleva M. M., Lagutina N. P., Radysh I. V., Surovtsev V. V., Khanfer'yan R. A. Effektivnost' «LEOVIT GASTRO» pri zabolevaniyakh zheludochno-kishechnogo trakta// Remedium Povolzh'e. 2020. - № 2(179). - S. 20-21.
65. Pilat T. L., Lashina E. L., Kolyaskina M. M., Bezrukavnikova L. M., Korosteleva M. M., Gurevich K. G., Lagutina N. P., Khanfer'yan R. A. Vliyanie spetsializirovannogo dieticheskogo kokteilya s rastitel'nymi komponentami na reparativnye protsessy pri razlichnykh zabolevaniyakh zheludochno-kishechnogo trakta // Zhurnal Poliklinika. 2020- № 1(2). S. 100-110.
66. Pilat T. L., Radysh I. V., Surovtsev V. V., Korosteleva M. M., Khanfer'yan R. A. Dieticheskaya korrektsiya narushenii pishchevareniya i funktsii ZhKT posle dlitel'noi samoizolyatsii i karantina, a takzhe patsientov s SARS-CoV-2 v periode reabilitatsii//Meditsinskii sovet, 2020. - № 15. - S. 146-152.
67. Pilat T.L., Lashina E. L., Kolyaskina M. M., Bezrukavnikova L. M., Korosteleva M. M., Bessonov V. V., Gurevich K. G., Lagutina N. P., Khanfer'yan R. A. Effektivnost' spetsializirovannoi dietoterapii u patsientov s zabolevaniyami zheludochno-kishechnogo trakta// Terapiya. - № 1-2020. - S. 141-149.
68. Pilat T.L., Kuz'mina L. P., Bezrukavnikova L. M., Kolyaskina M. M., Korosteleva M. M., Ismatullaeva S. S., Khanfer'yan R. A. Dieticheskie lechebno-profilakticheskie produkty pitaniya v kompleksnoi terapii zabolevanii zheludochno-kishechnogo trakta, assotsiirovannykh s Helicobacter pylori // Meditsinskii sovet. 2021. - № 15. - S. 50-57.
69. T.L. Pilat, L. M. Bezrukavnikova, M. M. Kolyaskina, V. V. Bessonov, N. A. Anvarul, R. A. Khanfer'yan. Issledovanie effektivnosti detoksitsiruyushchego vliyaniya kompleksnoi programmy pitaniya DETOX na funktsional'nye pokazateli organizma. Terapiya. 2020. № 2. S. 156-163.
70. Metodicheskie rekomendatsii «Izuchenie klinicheskoi effektivnosti primeneniya kompleksnoi programmy pitaniya «DETOX» («DETOKS») / Kolyaskina M. M., Sorokina N. S., Bezrukavnikova L. M. i dr. - M., 2019. - 22 s.
71. Pilat T.L., Kuz'mina L. P., Kolyaskina M. M., Radysh I. V., Khanfer'yan R. A. Spetsializirovannaya nutritivnaya podderzhka patsientov s COVID-19 dieticheskimi lechebnymi produktami pitaniya v usloviyakh statsionara // Terapiya. 2021. - № 2 (44)/T.7. - S. 153-159.
72. Pilat T.L., Alekseenko S. N., Krutova V. A., Akimov M. Yu., Radysh I. V., Umnova T. N., Istomin A. V., Gordeeva E. A., Korosteleva M. M., Khanfer'yan R. A. Problemy pitaniya bol'nykh COVID-19-virusnoi infektsiei i vozmozhnosti nutritivnoi korrektsii narushenii // Meditsinskii sovet. 2021. - № 4. - S. 144-154.
73. Pilat T.L., Istomin A. V., Gordeeva E. A., Khanfer'yan R. A. Mozhet li detoksikatsionnoe pitanie byt' vspomogatel'nym sredstvom pri lechenii i reabilitatsii bol'nykh, infitsirovannykh virusom COVID-19 // Lechashchii vrach. 2021. - № 4. - S. 43-49.
74. Kuz'mina L.P., Pilat T. L., Bezrukavnikova L. M., Kolyaskina M. M. Otsenka laboratornykh pokazatelei endogennoi intoksikatsii pri razlichnykh patologiyakh professional'noi i infektsionnoi etiologii // Terapiya. 2021. - № 9. - S. 174-182.
75. Pilat T. L., Kuz'mina L. P., Kolyaskina M. M., Bezrukavnikova L. M. Rol' zheludochno-kishechnogo trakta v protsessakh intoksikatsii i detoksikatsii organizma // Eksperimental'naya i klinicheskaya gastroenterologiya. 2020. - Vyp. 183,№ 11. - S. 118-125.
76. Kali A., Charles M. V.P., SrirangarajS. Cadazolid: A new hope in the treatmentof Clostridium difficile infection. Australas. Med. J. - 2015. - № 8(8). - R. 253-262.
77. Sinclair A., Xie X., Saab L. et al. Lactobacillus probiotics in the prevention of diarrhea associated with Clostridium difficile: a systematic review and Bayesian hierarchical meta-analysis //CMAJ open. - 2016. - T. 4. - №. 4. - R. E706
78. Guo S., Yan W., McDonough S.P. et al. The recombinant Lactococcus lactis oral vaccine induces protection against C. difficile spore challenge in a mouse model. Vaccine. - 2015. - № 13 (33). - R. 1586-1595
79. Lau C. S., Chamberlain R. S. Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis.Int. J. Gen. Med. DovePress, - 2016. - № 9. - R. 27-37.
Review
For citations:
Pilat T.L., Lazebnik L.B., Kuznetzova Y.G., Khanferyan R.A. Features of diet therapy for Clostridium difficile- associated disease. Experimental and Clinical Gastroenterology. 2022;(9):229-239. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-205-9-229-239
Views:
1899
ISSN 1682-8658 (Print)
Email this article 